Comparing human papillomavirus prevalences in women with normal cytology or invasive cervical cancer to rank genotypes according to their oncogenic potential: a meta-analysis of observational studies

Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer

(2012) Peng Guan et al.   INTERNATIONAL JOURNAL OF CANCER

Reevaluation of Epidemiological Data Demonstrates That It Is Consistent With Cross-Immunity Among Human Papillomavirus Types

(2012) D. P. Durham et al.   JOURNAL OF INFECTIOUS DISEASES

Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis

(2012) Talía Malagón et al.   LANCET INFECTIOUS DISEASES

Potential overestimation of HPV vaccine impact due to unmasking of non-vaccine types: Quantification using a multi-type mathematical model

(2012) Yoon Hong Choi et al.   VACCINE

Exploring individual HPV coinfections is essential to predict HPV-vaccination impact on genotype distribution: A model-based approach

(2012) Margarita Pons-Salort et al.   VACCINE

Human papillomavirus type 58: the unique role in cervical cancers in East Asia

(2012) Paul KS Chan   Cell and Bioscience

Human papillomavirus infection in women with and without cervical cancer in Tbilisi, Georgia

(2011) Tamar Alibegashvili et al.   Cancer Epidemiology

Human Papillomavirus (HPV) Genotypes in Women with Cervical Precancer and Cancer at Kaiser Permanente Northern California

(2011) P. E. Castle et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Eurogin 2010 roadmap on cervical cancer prevention

(2011) Silvia Franceschi et al.   INTERNATIONAL JOURNAL OF CANCER

For Cancers Caused by HPV, Two Vaccines Were Just the Beginning

(2011) J. Peres   JNCI-Journal of the National Cancer Institute

Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice

(2011) Hormuzd A Katki et al.   LANCET ONCOLOGY

A Population-Based Prospective Study of Carcinogenic Human Papillomavirus Variant Lineages, Viral Persistence, and Cervical Neoplasia

(2010) M. Schiffman et al.   CANCER RESEARCH

Multiplexed Serologic Assay for Nine Anogenital Human Papillomavirus Types

(2010) D. Opalka et al.   Clinical and Vaccine Immunology

Prevalence of genital human papillomavirus infection and genotypes among women from Fujian province, PR China

(2010) Dongmei Wu et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Prevalence and distribution of human papillomavirus types in cervical cancer, squamous intraepithelial lesions, and with no intraepithelial lesions in women from Southern Mexico

(2010) Berenice Illades-Aguiar et al.   GYNECOLOGIC ONCOLOGY

Human papillomavirus infection in a population-based sample of women in Algiers, Algeria

(2010) Doudja Hammouda et al.   INTERNATIONAL JOURNAL OF CANCER

Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication

(2010) Ni Li et al.   INTERNATIONAL JOURNAL OF CANCER

Prevalence and Type Distribution of Human Papillomavirus in Women With Cervical Lesions in Liaoning Province, China

(2010) Xia Liu et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Cervical Human Papillomavirus Prevalence in 5 Continents: Meta‐Analysis of 1 Million Women with Normal Cytological Findings

(2010) Laia Bruni et al.   JOURNAL OF INFECTIOUS DISEASES

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

(2010) Silvia de Sanjose et al.   LANCET ONCOLOGY

Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments

(2010) Hans-Ulrich Bernard et al.   VIROLOGY

HPV infection in women with and without cervical cancer in Conakry, Guinea

(2009) N Keita et al.   BRITISH JOURNAL OF CANCER

Human papillomavirus infection in women with and without cervical cancer in Nepal

(2009) Ang Tshering Lama Sherpa et al.   CANCER CAUSES & CONTROL

Human Papillomavirus Cofactors by Disease Progression and Human Papillomavirus Types in the Study to Understand Cervical Cancer Early Endpoints and Determinants

(2009) S. S. Wang et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

(2009) J Paavonen et al.   LANCET

A review of human carcinogens—Part B: biological agents

(2009) Véronique Bouvard et al.   LANCET ONCOLOGY

Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline

(2009) Mark Schiffman et al.   Infectious Agents and Cancer

The evolving definition of carcinogenic human papillomavirus

(2009) Philip E Castle   Infectious Agents and Cancer

Persistent Human Papillomavirus Infection and Cervical Neoplasia: A Systematic Review and Meta-Analysis

(2008) J. Koshiol et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

A Systematic Review of the Prevalence and Attribution of Human Papillomavirus Types among Cervical, Vaginal, and Vulvar Precancers and Cancers in the United States

(2008) R. P. Insinga et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland

(2008) A. Bardin et al.   EUROPEAN JOURNAL OF CANCER

Cervical carcinoma in Southern Mexico: Human papillomavirus and cofactors

(2008) Berenice Illades-Aguiar et al.   Cancer Detection and Prevention

Distribution of human papillomavirus genotypes in the patients with cervical carcinoma and its precursors in Zhejiang Province, China

(2007) D. HONG et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER